Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07616167 · ClinicalTrials.gov registry record · NA
This Study Evaluates the Use of a Data-driven Lower Limb Exoskeleton Controller for Stroke Rehabilitation.
A NA study, sponsored by University of Michigan.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07616167: Clinical Trial NA study, sponsored by University of Michigan.
NCT07616167 is a NA study that has not yet begun recruiting, run by University of Michigan. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07616167, a NA study, has not yet begun recruiting, sponsored by University of Michigan.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test a new, impairment-aware robotic control software framework to see if its smart adaptation can improve walking recovery in healthy adults and chronic stroke survivors. . The main questions it aims to answer are: Can the new control software safely use sensors and machine learning to predict and instantly adapt to a user's specific walking needs? Does training with a robotic device driven by this new adaptive control framework improve walking speed and overall mobility in stroke survivors? Researchers will compare a lower-limb orthosis operating under the new "smart" control software (which adapts to the user's impairment) to the same device operating under a standard, non-adaptive controller (which uses rigid or fixed assistance) to see if the new control approach leads to greater improvements in walking ability. Participants will: Walk on treadmills, flat walkways, or stairs while wearing a robotic leg orthosis driven by the different control software systems being tested. Wear small tracking tools (like reflective motion-capture markers and muscle activity sensors) so researchers can precisely measure how their movements interact with each control program. Complete standard walking tests to measure their walking speed and overall mobility under each software condition.
Primary Outcome
A standardized clinical assessment used to determine short-distance walking speed over a 10-meter course. This metric evaluates the preliminary clinical efficacy of the unified control framework compared to the conventional controller in chronic stroke survivors.
Interventions
- DEVICE Unified Control Framework for Lower-Limb Powered Orthosis
- DEVICE Conventional Robotic Controller
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What is known before NCT07616167 opens enrollment
NCT07616167 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Unified Control Framework for Lower-Limb Powered Orthosis is the first listed.
NCT07616167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07616167 about?
NCT07616167 is a clinical study titled "This Study Evaluates the Use of a Data-driven Lower Limb Exoskeleton Controller for Stroke Rehabilitation.". The goal of this clinical trial is to test a new, impairment-aware robotic control software framework to see if its smart adaptation can improve walking recovery in healthy adults and chronic stroke survivors. . The main questions it aims to answer are: Can the new control software safely use sens...
What is the current status of trial NCT07616167?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-10-01. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07616167?
The interventions under investigation include: Unified Control Framework for Lower-Limb Powered Orthosis (DEVICE), Conventional Robotic Controller (DEVICE).
Who is sponsoring clinical trial NCT07616167?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07616167's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI